Earnings Feed
Start Free
Home/Filings/4/0001062993-24-010179
4//SEC Filing

Frieberg Jacob B. 4

Accession 0001062993-24-010179

CIK 0001205922other
View on SEC.govCompany Profile

Filed

May 13, 8:00 PM ET

Accepted

May 14, 4:32 PM ET

Size

40.5 KB

Accession

0001062993-24-010179

Insider Transaction Report

Form 4
Period: 2024-05-10
VACCINEX, INC.VCNX
Frieberg Jacob B.
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-05-10+10,108→ 10,108 total
    Exercise: $5.75From: 2025-05-10→ Common Stock (10,108 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-05-10$3.96/sh+2,211$8,756→ 2,211 total
    Exercise: $5.75From: 2024-05-10Exp: 2034-05-10→ Common Stock (2,211 underlying)
Holdings

  • Common Stock

    (indirect: By Gee Eff Services Limited)
    920

  • Stock Option (Right to Buy)

    Exercise: $1018.50Exp: 2029-12-28→ Common Stock (13 underlying)
    13

  • Stock Option (Right to Buy)

    Exercise: $1159.20Exp: 2029-06-29→ Common Stock (11 underlying)
    11

  • Stock Option (Right to Buy)

    Exercise: $453.60Exp: 2031-09-28→ Common Stock (29 underlying)
    29

  • Stock Option (Right to Buy)

    Exercise: $218.40Exp: 2031-12-29→ Common Stock (61 underlying)
    61

  • Stock Option (Right to Buy)

    Exercise: $235.20→ Common Stock (253 underlying)
    253

  • Stock Option (Right to Buy)

    Exercise: $135.52Exp: 2032-12-28→ Common Stock (94 underlying)
    94

  • Stock Option (Right to Buy)

    Exercise: $83.86Exp: 2033-03-28→ Common Stock (152 underlying)
    152

  • Common Stock

    303

  • Stock Option (Right to Buy)

    Exercise: $1505.70Exp: 2029-09-27→ Common Stock (8 underlying)
    8

  • Stock Option (Right to Buy)

    Exercise: $840.00Exp: 2030-03-29→ Common Stock (15 underlying)
    15

  • Stock Option (Right to Buy)

    Exercise: $1104.60Exp: 2029-03-30→ Common Stock (11 underlying)
    11

  • Stock Option (Right to Buy)

    Exercise: $829.50→ Common Stock (74 underlying)
    74

  • Stock Option (Right to Buy)

    Exercise: $104.02Exp: 2032-09-27→ Common Stock (125 underlying)
    125

  • Stock Option (Right to Buy)

    Exercise: $373.80Exp: 2030-09-28→ Common Stock (36 underlying)
    36

  • Common Stock

    (indirect: By Benbow Estates, Ltd.)
    451

  • Stock Option (Right to Buy)

    Exercise: $1633.80→ Common Stock (36 underlying)
    36

  • Stock Option (Right to Buy)

    Exercise: $451.50→ Common Stock (136 underlying)
    136

  • Stock Option (Right to Buy)

    Exercise: $86.10→ Common Stock (684 underlying)
    684

  • Stock Option (Right to Buy)

    Exercise: $74.76Exp: 2033-06-27→ Common Stock (172 underlying)
    172

  • Stock Option (Right to Buy)

    Exercise: $758.10Exp: 2030-06-28→ Common Stock (17 underlying)
    17

  • Stock Option (Right to Buy)

    Exercise: $625.80Exp: 2031-03-31→ Common Stock (21 underlying)
    21

  • Stock Option (Right to Buy)

    Exercise: $2856.00Exp: 2027-09-15→ Common Stock (30 underlying)
    30

  • Stock Option (Right to Buy)

    Exercise: $434.70Exp: 2030-12-29→ Common Stock (31 underlying)
    31

  • Stock Option (Right to Buy)

    Exercise: $588.00Exp: 2031-06-28→ Common Stock (22 underlying)
    22

  • Stock Option (Right to Buy)

    Exercise: $277.20Exp: 2032-03-28→ Common Stock (47 underlying)
    47

  • Stock Option (Right to Buy)

    Exercise: $226.80Exp: 2032-06-27→ Common Stock (57 underlying)
    57
Footnotes (10)
  • [F1]Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F10]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first.
  • [F2]Mr. Frieberg is the sole owner and President of Gee Eff Services Limited.
  • [F3]Exercisable in full as of the date of this report.
  • [F4]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
  • [F5]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
  • [F6]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
  • [F7]This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
  • [F8]This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
  • [F9]Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the first quarter of 2024. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.

Documents

1 file

Issuer

VACCINEX, INC.

CIK 0001205922

→
Entity typeother

Related Parties

1
  • filerCIK 0001748346

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:32 PM ET
Size
40.5 KB
View on SEC.gov